Long Non-Coding Mitochondrial RNAs as Novel Molecular Target for Bladder Cancer Treatment
Bladder cancer (BC) is the sixth most common cause of cancer; BC risk increases with age and is more common among men than women. Upon diagnosis, the 5-year relative survival rate for patients is approximately 77%. The treatment options available for bladder cancer include chemotherapy, radiation th...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2022
|
| Subjects: | |
| Online Access: | https://www.intechopen.com/chapters/85092 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Long Non-Coding Mitochondrial RNAs as Novel Molecular Target for Bladder Cancer Treatment
- Autologous Immunotherapy as a Novel Treatment for Bladder Cancer
- Molecular Classification of Bladder Cancer
- Chemoprevention and Novel Treatments of Non-Muscle Invasive Bladder Cancer
- The Molecular Basis of Cisplatin Resistance in Bladder Cancer Cells
- Clonamiento, expresión y caracterización de las subsiformas de la proteínaquinasa CK1a de pez cebra (Danio rerio)
- Cancer and mitochondrial function